Li Q F, Rabie A B M
The Biomedical and Tissue Engineering Group, Department of Orthodontics, Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Hong Kong SAR, China.
Arch Oral Biol. 2007 Nov;52(11):1009-17. doi: 10.1016/j.archoralbio.2007.05.009. Epub 2007 Jul 20.
To provide a comprehensive review of the mechanisms of growth of mandibular condyle, the roles of angiogenesis enhancers and inhibitors during endochondral ossification in mandibular condyle and newly developed delivery methods for local gene delivery that may represent strategies to regulate condylar growth.
Narrative review.
Angiogenesis is the crucial step in mandibular condylar growth for it regulates the transformation from cartilage to bone. Angiognesis enhancers, especially VEGF and FGF, play important roles in the process of new blood lumen formation and invasion. On the other hand, angiostatin and endostatin inhibit angiogenesis by targeting endothelial cells and several signal cascades. Delivery methods such as liposomes, stem cells and virus vectors have been studied. Recombinant AAV-mediated gene therapy is considered as one of the most promising strategies of condylar growth management.
AAV-mediated gene therapy using VEGF or angiogenesis inhibitor will be a promising way to regulate condylar growth at an early stage.
全面综述下颌髁突生长机制、血管生成增强剂和抑制剂在髁突软骨内成骨过程中的作用以及新开发的局部基因递送方法,这些方法可能代表调节髁突生长的策略。
叙述性综述。
血管生成是下颌髁突生长的关键步骤,因为它调节软骨向骨的转化。血管生成增强剂,尤其是血管内皮生长因子(VEGF)和成纤维细胞生长因子(FGF),在新血管腔形成和侵入过程中起重要作用。另一方面,血管抑素和内皮抑素通过作用于内皮细胞和多个信号级联反应来抑制血管生成。脂质体、干细胞和病毒载体等递送方法已得到研究。重组腺相关病毒(AAV)介导的基因治疗被认为是髁突生长管理最有前景的策略之一。
使用VEGF或血管生成抑制剂的AAV介导的基因治疗将是早期调节髁突生长的一种有前景的方法。